Experience with mesna in patients receiving allogeneic bone marrow transplants for poor prognostic leukaemia.
D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects*; D003556:Cystitis / Q000139:chemically induced / Q000517:prevention & control; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D008297:Male; D008623:Mercaptoethanol / Q000031:analogs & derivatives*; D015080:Mesna / Q000627:therapeutic use*
D008623:Mercaptoethanol; D003520:Cyclophosphamide; D015080:Mesna